Clay Ritchey is the Chief Executive Officer of Definitive Healthcare, a healthcare data and analytics company that helps organizations understand the complex business side of healthcare. He took on the role on September 8, 2026, bringing extensive experience in healthcare technology, data management, and business leadership.
Throughout his career, Ritchey has led companies that develop technology to help healthcare organizations manage information, improve operations, and make better business decisions. His background in healthcare data and technology positions him to guide Definitive Healthcare as it develops its platform and expands its use of artificial intelligence.
Leading Definitive Healthcare
Definitive Healthcare provides data, analytics, and technology solutions that help businesses make sense of the healthcare market. Its customers use the company's information to identify opportunities, understand market activity, evaluate organizations, and support commercial decisions.
The healthcare industry involves a large network of hospitals, physicians, health systems, medical groups, suppliers, and other organizations. Understanding how these entities connect can be difficult without reliable data. Definitive Healthcare aims to make this information easier to access and use.
When Ritchey joined the company, he highlighted its proprietary datasets and growing portfolio of solutions as important assets. He also pointed to the company's plans for an AI-powered platform combining healthcare data with conversational AI and workflows. The goal is to help customers get more value from the information they already use.
Ritchey succeeds Kevin Coop, who stepped down as CEO and board member at the end of August 2026. His appointment reflects the company's focus on returning to growth, improving business performance, and developing its technology offering.
Previous Leadership at Verato
Before joining Definitive Healthcare, Ritchey served as Chief Executive Officer of Verato from April 2021 to May 2026. Verato specializes in healthcare identity management and master data management.
Healthcare organizations often hold information about the same patient, member, or consumer across multiple systems. Differences in records can create duplicate identities and make it harder to build a complete view of an individual. Verato develops technology that helps organizations connect these records and establish more reliable identity information.
During his time at Verato, Ritchey focused on the business opportunities created by solving healthcare data identity challenges. In an interview with HIStalk, he explained how accurate identity information supports data exchange, operational efficiency, and better patient experiences.
After leaving the CEO position in May 2026, he served as an advisor to Verato's board beginning in June 2026.
Earlier Career in Healthcare Technology
Ritchey has held several senior positions across healthcare technology companies.
From March 2017 to April 2020, he was Chief Executive Officer of Evariant, a healthcare technology company focused on customer relationship management and analytics. Evariant was subsequently acquired by Healthgrades.
Before Evariant, Ritchey served as Chief Marketing Officer at Imprivata from October 2013 to March 2017. Imprivata provides digital identity and access management technology, including solutions designed for healthcare environments. His role involved senior marketing leadership in a sector where security, identity, and access to information are essential.
Earlier, he was Chief Executive Officer of Equinox Healthcare from April 2010 to April 2013. During his tenure, he led the company's sale to AxelaCare Health Solutions.
His career also includes senior marketing and go-to-market positions at Hill-Rom and Kronos. These roles gave him experience across healthcare products, enterprise technology, commercial strategy, and business development.
Leadership Focus and Industry Perspective
Ritchey's career has consistently involved businesses that help healthcare organizations use information more effectively. His experience covers several connected areas: healthcare data, identity management, analytics, digital technology, and commercial growth.
One recurring theme in his work is the importance of reliable data. Healthcare organizations depend on accurate information to understand patients, manage relationships, coordinate services, and make operational decisions. Technology can provide significant value, but only when the underlying information is dependable and useful.
His appointment at Definitive Healthcare brings this experience to a company operating at the intersection of healthcare data and commercial intelligence. The company's planned AI-powered platform also creates an opportunity to make complex healthcare information more accessible through conversational tools and integrated workflows.
Ritchey's stated goal upon joining was to help accelerate Definitive Healthcare's return to growth. Delivering on that ambition will involve developing the company's products, creating value for customers, and improving its financial and operational performance.
Clay Ritchey: Key Facts
| Category | Details |
|---|---|
| Full Name | Clay Ritchey |
| Current Position | Chief Executive Officer |
| Company | Definitive Healthcare |
| Appointment Date | September 8, 2026 |
| Industry | Healthcare Technology and Data Analytics |
| Previous Position | CEO of Verato |
| Other Leadership Roles | CEO of Evariant; CMO of Imprivata; CEO of Equinox Healthcare |
| Earlier Companies | Hill-Rom and Kronos |
| Education | Pennsylvania State University; Harvard Business School |
Clay Ritchey's appointment brings a healthcare technology executive with extensive experience in data management and commercial leadership to Definitive Healthcare. His next chapter will center on helping the company strengthen its market position, develop its AI-powered capabilities, and deliver practical intelligence to organizations across the healthcare industry.
Welcome to CEO Watch, where we take stock of the business world's major players, while providing weekly news roundups from the world of Wall Street. Here we profile the CEOs and their firms – those reinventing their companies amid bleak economic times and those unlikely to recover from historic losses. We tally Corporate America's wins and losses while providing insight into the capitalism's insiders. We mean business.
